BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16734730)

  • 41. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
    Tsujie M; Nakamori S; Nakahira S; Takeda S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Pancreas; 2006 Aug; 33(2):142-7. PubMed ID: 16868479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticancer activity and toxicity of S-1, an oral combination of tegafur and two biochemical modulators, compared with continuous i.v. infusion of 5-fluorouracil.
    Fukushima M; Shimamoto Y; Kato T; Uchida J; Yonekura R; Ohshimo H; Shirasaka T
    Anticancer Drugs; 1998 Oct; 9(9):817-23. PubMed ID: 9840729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
    Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H
    Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Capecitabine: preclinical pharmacology studies.
    Ishitsuka H
    Invest New Drugs; 2000 Nov; 18(4):343-54. PubMed ID: 11081570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
    Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of drug chemosensitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung cancer cells.
    Osaki S; Nakanishi Y; Takayama K; Pei XH; Ueno H; Hara N
    Cancer Gene Ther; 2000 Feb; 7(2):300-7. PubMed ID: 10770640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.
    Humeniuk R; Mishra PJ; Bertino JR; Banerjee D
    Mol Cancer Ther; 2009 May; 8(5):1045-54. PubMed ID: 19383845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of human equilibrative nucleoside transporter 1 by RNAi enhances 5-fluorouracil response in pancreatic cancer.
    Hu X; Chen W; Xu J
    Hepatogastroenterology; 2010; 57(104):1567-72. PubMed ID: 21443122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral DPD-inhibitory fluoropyrimidine drugs.
    Diasio RB
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):19-23. PubMed ID: 11098485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5-fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis.
    Hayashi M; Kawakubo H; Fukuda K; Mayanagi S; Nakamura R; Suda K; Hayashida T; Wada N; Kitagawa Y
    J Gene Med; 2019 Dec; 21(12):e3135. PubMed ID: 31656051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma.
    Wang J; Liu W; Zhao Q; Qi Q; Lu N; Yang Y; Nei FF; Rong JJ; You QD; Guo QL
    Toxicology; 2009 Feb; 256(1-2):135-40. PubMed ID: 19084572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.
    Kirihara Y; Yamamoto W; Toge T; Nishiyama M
    Int J Oncol; 1999 Mar; 14(3):551-6. PubMed ID: 10024690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
    Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
    Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts.
    Yamamoto S; Kurebayashi J; Kurosumi M; Kunisue H; Otsuki T; Tanaka K; Sonoo H
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):283-8. PubMed ID: 11710628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral 5-FU is a more effective antimetastatic agent than UFT.
    Wang J; Yang M; Yagi S; Hoffman RM
    Anticancer Res; 2004; 24(3a):1353-60. PubMed ID: 15274295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human equilibrative nucleoside transporter 1, as a predictor of 5-fluorouracil resistance in human pancreatic cancer.
    Tsujie M; Nakamori S; Nakahira S; Takahashi Y; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Anticancer Res; 2007; 27(4B):2241-9. PubMed ID: 17695509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of 5-fluorouracil metabolism-relating enzymes and enhanced chemosensitivity to 5-fluorouracil by 5-chloro 2,4-dihydroxy-pyridine in urothelial carcinoma.
    Ide H; Kikuchi E; Hasegawa M; Kozakai N; Kosaka T; Miyajima A; Oya M
    BMC Cancer; 2012 Sep; 12():420. PubMed ID: 22998564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.